Pharmafile Logo

Speak First

Speak First is all about three things – confidence, impact and clarity. Our communication skills training and coaching is guaranteed to enhance business relationships. With over 20 years’ experience, we are global specialists in soft skills training essential for business success. Our expertise include: presentation skills, personal impact, media training, selling and negotiation skills, business writing, NLP for Business and other interpersonal and communication skills training to improve workplace effectiveness and career success.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Amiculum

AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…

View Profile

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.

View Profile

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Company Details

1st Floor, 20 Old Street, London, EC1V 9AB, United Kingdom
+44 (0)20 7253 2117

 Latest Content from PMHub 

Why can’t we use Google Maps to understand patient journeys?

Patient experiences are diverse and dynamic. Mapping patient journeys enables us to unlock salient insights and redesign care pathways.

Is agile working benefiting the employee or the organisation?

Angela Young, HR Director Lucid Group discusses the pros and cons of agile working in the latest “Smart Thinking” blog on pmlive.com

Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies

Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Unique forum will unite NHS and industry to drive innovation

HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare

Living with haemophilia – the power of knowledge

Each week, we are inundated with articles emphasising the importance of regular exercise. On World Hemophilia Day, Porterhouse Medical explores changing attitudes towards exercising with the disease and share guides...

IBD Registry appoints first CEO

Press Releases | April 13, 2018 | Dovetail

The IBD Registry Board is delighted to announce the appointment of Liz Dobson as the first Chief Executive Officer of IBD Registry Ltd from 16th April 2018.   The IBD...

Perspective on the power of insight

In this issue of Perspective magazine, our in-house insight experts unite to reveal the best practical tools, tips and knowledge for harnessing insight to empower your customers and inspire innovation.

Impact of data sharing

With the General Data Protection Regulation (GDPR) on the horizon, the Cambridge Analytica scandal has provided a stark reminder of the importance of data protection laws.

No one is listening to you!

We know it is harsh but you know how frustrating it is. You want them to embrace change but they’ve got cloth ears. That’s why we have produced a guide,...

How can pharma engage with key decision-makers in new, collaborative NHS care models?

Paul Midgley, Sue Thomas, Steve How and Oli Hudson, of Wilmington Healthcare, explore how pharma should adapt its approach